Trump administration proposes fees on e-cigarette industry to fund FDA regulatory oversight; Scientists create bioprinter that allows creation of new skin to treat wounds; Medieval era diseases reappear in unsanitary locations among homeless populations and others.
The e-cigarette industry would face $100 million in annual user fees resulting from the Trump administration’s new budget proposal, The Washington Post reported. Accrued funds would be used to pay for regulatory oversight by the FDA. The measure must first be approved by Congress. Fees would be imposed upon manufacturers and importers of e-cigarette devices and e-liquids. Advocates for the industry have criticized the proposal, calling it a tax, as they continue to market e-cigarettes as a safe alternative to traditional smoking.
A new bioprinter that uses an individual’s own skin cells to produce new layers of skin has been created by scientists at the Wake Forest Institute for Regenerative Medicine, Medical News Today reported. The new skin would be used to treat wounds without requiring donor skin grafts. The procedure collects major skin cells, expands them, and mixes them into a hydrogel which is placed into a bioprinter. The technique aspires to replicate the natural function of skin and speed up the healing process.
Infectious diseases that were prevalent in the medieval era have reappeared within homeless populations in California and other unsanitary locations nationwide, Kaiser Health News reported. These dangerous diseases including typhus, hepatitis A, and shigellosis have spread widely and quickly in contaminated areas. Risk of contagion is not limited to the homeless population, creating the possibility for a public health crisis.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More